Santen Pharmaceutical Co., Ltd. revenue breakdown overview

Santen Pharmaceutical Co., Ltd. revenue for the last year amounted to 2.00 B USD, the most of which — 1.86 B USD — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 1.96 B USD. The greatest contribution to the revenue figure was made by Japan — last year it brought Santen Pharmaceutical Co., Ltd. 1.16 B USD, and the year before that — 1.34 B USD.